Stay updated on IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Sign up to get notified when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.

Latest updates to the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now includes Revision: v3.4.2 as an addition. The funding notice and the previous Revision: v3.4.1 entry were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the system revision was updated to v3.4.1, replacing the previous v3.4.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedThe record history page now shows a glossary, uses green highlights for additions and red highlights for deletions, and updates the revision label to v3.4.0; no core study data are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedRevision v3.3.4 was added and Revision v3.3.3 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing the 'HHS Vulnerability Disclosure' link as well as the older 'Revision: v3.3.2'.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page's footer revision label was updated from v3.2.0 to v3.3.2, a minor site maintenance detail that does not affect trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMmotion151: Atezo + Bev vs Sunitinib in Untreated Adv RCC Clinical Trial page.